{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T04:23:14Z","timestamp":1744777394934,"version":"3.40.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03773-7","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T15:55:31Z","timestamp":1744732531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of ultrasound signs of sarcopenia with serum ferritin levels and hepatic indices like NFS and FIB-4 in NAFLD patients"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0136-3937","authenticated-orcid":false,"given":"Bahar","family":"Arasteh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5344-4885","authenticated-orcid":false,"given":"Sina","family":"Hamzehzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6782-8342","authenticated-orcid":false,"given":"Kia Seyed","family":"Toutounchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6522-1048","authenticated-orcid":false,"given":"Zeinab","family":"Nikniaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1733-1462","authenticated-orcid":false,"given":"Leila","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9764-7713","authenticated-orcid":false,"given":"Leila","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"issue":"10290","key":"3773_CR1","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW-S, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324.","journal-title":"Lancet"},{"key":"3773_CR2","doi-asserted-by":"crossref","unstructured":"Funke K, Rockey DC. Cholestatic Drug-Induced liver injury caused by mifepristone. Hepatology. 2019;69(6).","DOI":"10.1002\/hep.30465"},{"issue":"5","key":"3773_CR3","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1007\/s10620-016-4079-4","volume":"61","author":"DH Kaswala","year":"2016","unstructured":"Kaswala DH, Lai M, Afdhal NH. Fibrosis assessment in nonalcoholic fatty liver disease (NAFLD) in 2016. Dig Dis Sci. 2016;61(5):1356\u201364.","journal-title":"Dig Dis Sci"},{"issue":"10","key":"3773_CR4","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184(10):2537\u201364.","journal-title":"Cell"},{"issue":"1","key":"3773_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u20139.","journal-title":"J Hepatol"},{"key":"3773_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","volume":"92","author":"SA Polyzos","year":"2019","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Metabolism. 2019;92:82\u201397.","journal-title":"Metabolism"},{"issue":"19","key":"3773_CR7","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1001\/archinte.164.19.2169","volume":"164","author":"HJ Kim","year":"2004","unstructured":"Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW, et al. Metabolic significance of nonalcoholic fatty liver disease in Nonobese, nondiabetic adults. Arch Intern Med. 2004;164(19):2169\u201375.","journal-title":"Arch Intern Med"},{"issue":"4","key":"3773_CR8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71(4):793\u2013801.","journal-title":"J Hepatol"},{"issue":"38","key":"3773_CR9","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.2174\/1381612825666190117102111","volume":"24","author":"M Papatheodoridi","year":"2018","unstructured":"Papatheodoridi M, Cholongitas E. Diagnosis of non-alcoholic fatty liver disease (NAFLD): current concepts. Curr Pharm Design. 2018;24(38):4574\u201386.","journal-title":"Curr Pharm Design"},{"issue":"1","key":"3773_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12876-022-02098-z","volume":"22","author":"Q Chen","year":"2022","unstructured":"Chen Q, Gao M, Yang H, Mei L, Zhong R, Han P, et al. Serum ferritin levels are associated with advanced liver fibrosis in treatment-naive autoimmune hepatitis. BMC Gastroenterol. 2022;22(1):23.","journal-title":"BMC Gastroenterol"},{"issue":"8","key":"3773_CR11","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3748\/wjg.v19.i8.1219","volume":"19","author":"S Treeprasertsuk","year":"2013","unstructured":"Treeprasertsuk S, Bj\u00f6rnsson E, Enders F, Suwanwalaikorn S, Lindor KD. NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients. World J Gastroenterology: WJG. 2013;19(8):1219.","journal-title":"World J Gastroenterology: WJG"},{"issue":"1","key":"3773_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12876-022-02290-1","volume":"22","author":"A Sugiyama","year":"2022","unstructured":"Sugiyama A, Kurisu A, Ouoba EB, Ko S, Rakhimov K. Distribution of FIB-4 index in the general population: analysis of 75,666 residents who underwent health checkups. BMC Gastroenterol. 2022;22(1):241.","journal-title":"BMC Gastroenterol"},{"key":"3773_CR13","doi-asserted-by":"publisher","first-page":"774030","DOI":"10.3389\/fnut.2021.774030","volume":"8","author":"V Zambon Azevedo","year":"2021","unstructured":"Zambon Azevedo V, Silaghi CA, Maurel T, Silaghi H, Ratziu V, Pais R. Impact of sarcopenia on the severity of the liver damage in patients with Non-alcoholic fatty liver disease. Front Nutr. 2021;8:774030.","journal-title":"Front Nutr"},{"issue":"4","key":"3773_CR14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jocd.2015.04.013","volume":"18","author":"JA Cauley","year":"2015","unstructured":"Cauley JA. An overview of sarcopenic obesity. J Clin Densitometry. 2015;18(4):499\u2013505.","journal-title":"J Clin Densitometry"},{"issue":"3","key":"3773_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s42000-018-0049-x","volume":"17","author":"SA Polyzos","year":"2018","unstructured":"Polyzos SA, Margioris AN. Sarcopenic obesity. Hormones. 2018;17(3):321\u201331.","journal-title":"Hormones"},{"issue":"6","key":"3773_CR16","doi-asserted-by":"publisher","first-page":"e100118","DOI":"10.1371\/journal.pone.0100118","volume":"9","author":"TN Kim","year":"2014","unstructured":"Kim TN, Park MS, Kim YJ, Lee EJ, Kim M-K, Kim JM, et al. Association of low muscle mass and combined low muscle mass and visceral obesity with low cardiorespiratory fitness. PLoS ONE. 2014;9(6):e100118.","journal-title":"PLoS ONE"},{"key":"3773_CR17","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s12072-019-09996-7","volume":"13","author":"JA Kim","year":"2019","unstructured":"Kim JA, Choi KM. Sarcopenia and fatty liver disease. Hep Intl. 2019;13:674\u201387.","journal-title":"Hep Intl"},{"issue":"4","key":"3773_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.14283\/jfa.2018.24","volume":"7","author":"HJ Stringer","year":"2018","unstructured":"Stringer HJ, Wilson D. The role of ultrasound as a diagnostic tool for sarcopenia. J Frailty Aging. 2018;7(4):258\u201361.","journal-title":"J Frailty Aging"},{"issue":"2","key":"3773_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2021.4989","volume":"48","author":"H Nishikawa","year":"2021","unstructured":"Nishikawa H, Fukunishi S, Asai A, Yokohama K, Nishiguchi S, Higuchi K. Pathophysiology and mechanisms of primary sarcopenia. Int J Mol Med. 2021;48(2):1\u20138.","journal-title":"Int J Mol Med"},{"issue":"28","key":"3773_CR20","doi-asserted-by":"publisher","first-page":"9330","DOI":"10.3748\/wjg.v20.i28.9330","volume":"20","author":"S Mili\u0107","year":"2014","unstructured":"Mili\u0107 S, Luli\u0107 D, \u0160timac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterology: WJG. 2014;20(28):9330.","journal-title":"World J Gastroenterology: WJG"},{"issue":"1","key":"3773_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/life12010009","volume":"12","author":"J-C Wang","year":"2021","unstructured":"Wang J-C, Wu W-T, Chang K-V, Chen L-R, Chi S-Y, Kara M, et al. Ultrasound imaging for the diagnosis and evaluation of sarcopenia: an umbrella review. Life. 2021;12(1):9.","journal-title":"Life"},{"issue":"12","key":"3773_CR22","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/ggi.14720","volume":"23","author":"X Zhao","year":"2023","unstructured":"Zhao X, Zhang H, Yu J, Wang J. Association of possible sarcopenia with major chronic diseases and Multimorbidity among middle-aged and older adults: findings from a National cross-sectional study in China. Geriatr Gerontol Int. 2023;23(12):925\u201331.","journal-title":"Geriatr Gerontol Int"},{"issue":"10","key":"3773_CR23","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.3390\/jcm9103355","volume":"9","author":"Y Kwon","year":"2020","unstructured":"Kwon Y, Jeong SJ. Relative skeletal muscle mass is an important factor in non-alcoholic fatty liver disease in non-obese children and adolescents. J Clin Med. 2020;9(10):3355.","journal-title":"J Clin Med"},{"issue":"8","key":"3773_CR24","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1111\/liv.14852","volume":"41","author":"D Kim","year":"2021","unstructured":"Kim D, Wijarnpreecha K, Sandhu KK, Cholankeril G, Ahmed A. Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause\u2010specific mortality in the united States. Liver Int. 2021;41(8):1832\u201340.","journal-title":"Liver Int"},{"key":"3773_CR25","unstructured":"Joo SK, Kim W. Interaction between sarcopenia and NAFLD. Clin Mol Hepatol. 2022."},{"issue":"7","key":"3773_CR26","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s11739-023-03339-z","volume":"18","author":"G Tarantino","year":"2023","unstructured":"Tarantino G, Sinatti G, Citro V, Santini S Jr., Balsano C. Sarcopenia, a condition shared by various diseases: can we alleviate or delay the progression? Intern Emerg Med. 2023;18(7):1887\u201395.","journal-title":"Intern Emerg Med"},{"issue":"5","key":"3773_CR27","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/hep.26716","volume":"59","author":"HC Hong","year":"2014","unstructured":"Hong HC, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, et al. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean sarcopenic obesity study. Hepatology. 2014;59(5):1772\u20138.","journal-title":"Hepatology"},{"key":"3773_CR28","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1590\/1981-22562017020.160155","volume":"20","author":"KMM Margutti","year":"2017","unstructured":"Margutti KMM, Schuch NJ, Schwanke CHA. Inflammatory markers, sarcopenia and its diagnostic criteria among the elderly: a systematic review. Revista Brasileira De Geriatria E Gerontologia. 2017;20:441\u201353.","journal-title":"Revista Brasileira De Geriatria E Gerontologia"},{"issue":"1","key":"3773_CR29","doi-asserted-by":"publisher","first-page":"9179","DOI":"10.1038\/s41598-024-60059-w","volume":"14","author":"H Chen","year":"2024","unstructured":"Chen H, Zhang Z, Wang Y, Ma A, Li L, Zhao G. Iron status and sarcopenia-related traits: a bi-directional Mendelian randomization study. Sci Rep. 2024;14(1):9179.","journal-title":"Sci Rep"},{"issue":"4","key":"3773_CR30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1053\/j.jrn.2016.01.011","volume":"26","author":"C Nakagawa","year":"2016","unstructured":"Nakagawa C, Inaba M, Ishimura E, Yamakawa T, Shoji S, Okuno S. Association of increased serum ferritin with impaired muscle strength\/quality in Hemodialysis patients. J Ren Nutr. 2016;26(4):253\u20137.","journal-title":"J Ren Nutr"},{"issue":"12","key":"3773_CR31","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1007\/s40520-022-02242-5","volume":"34","author":"V Ho","year":"2022","unstructured":"Ho V, Lee C-T, Merchant RA. The iron Tale-iron indices and handgrip strength in community-dwelling adults. Aging Clin Exp Res. 2022;34(12):3025\u201332.","journal-title":"Aging Clin Exp Res"},{"key":"3773_CR32","doi-asserted-by":"crossref","unstructured":"Mendham AE, Brooks NE, Micklesfield LK, Faber M, Christensen DL, Gallagher IJ et al. Sarcopenia in older black South African women and relationships with physical activity and protein intake. The Proceedings of the Nutrition Society. 2020;79(OCE2).","DOI":"10.1017\/S0029665120000981"},{"issue":"12","key":"3773_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12032-020-01439-w","volume":"37","author":"D Zhou","year":"2020","unstructured":"Zhou D, Zhang Y, Mamtawla G, Wan S, Gao X, Zhang L, et al. Iron overload is related to muscle wasting in patients with cachexia of gastric cancer: using quantitative proteome analysis. Med Oncol. 2020;37(12):113.","journal-title":"Med Oncol"},{"key":"3773_CR34","doi-asserted-by":"publisher","first-page":"941093","DOI":"10.3389\/fnut.2022.941093","volume":"9","author":"Z Chen","year":"2022","unstructured":"Chen Z, Chen J, Song C, Sun J, Liu W. Association between serum iron status and muscle mass in adults: results from NHANES 2015\u20132018. Front Nutr. 2022;9:941093.","journal-title":"Front Nutr"},{"issue":"4","key":"3773_CR35","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/apt.13889","volume":"45","author":"S Petta","year":"2017","unstructured":"Petta S, Ciminnisi S, Di Marco V, Cabibi D, Camm\u00e0 C, Licata A, et al. Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2017;45(4):510\u20138.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"3773_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jhep.2016.08.019","volume":"66","author":"BK Koo","year":"2017","unstructured":"Koo BK, Kim D, Joo SK, Kim JH, Chang MS, Kim BG, et al. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. J Hepatol. 2017;66(1):123\u201331.","journal-title":"J Hepatol"},{"issue":"9","key":"3773_CR37","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1097\/MEG.0000000000001397","volume":"31","author":"K Wijarnpreecha","year":"2019","unstructured":"Wijarnpreecha K, Kim D, Raymond P, Scribani M, Ahmed A. Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA. Eur J Gastroenterol Hepatol. 2019;31(9):1121\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3773_CR38","doi-asserted-by":"crossref","unstructured":"Pan X, Han Y, Zou T, Zhu G, Xu K, Zheng J, Sarcopenia contributes to the progression of nonalcoholic fatty liver disease-related fibrosis: a meta-analysis. S., Karger et al. AG Basel, Switzerland; 2018. pp. 427\u2013\u200936.","DOI":"10.1159\/000491015"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03773-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03773-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03773-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T15:55:34Z","timestamp":1744732534000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03773-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3773"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03773-7","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"2 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study process was reviewed and approved by the ethics committee of Tabriz University of Medical Sciences, according to the declaration of Helsinki (ethics code: IR.TBZMED.REC.1400.853). Before collecting data, informed consent was obtained from all patients. All methods were carried out according to relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"261"}}